Larger VC Deals Could Become More Common In Devices
This article was originally published in Start Up
You may also be interested in...
Medical device companies raised $1.1 billion, a 40% increase over Q4 2011’s $800 million. Two billion-dollar deals in the resuscitation market boosted device acquisition activity to $4.2 billion. Twenty diagnostics financings brought in a collective $302 million, soaring above the previous quarter’s $269 million. There were seven diagnostics M&A deals completed, totaling $589 million – down yet again.
ConforMIS last month closed on an $89 million Series E round to help pay for the company’s commercial launch of iTotal, customized, patient-specific total knee implants.
Advances in small activating RNAs, pioneered by MiNA Therapeutics, have caught the eye of Eli Lilly, and could be the next platform to exploit gene control mechanisms to produce a new therapeutic modality.